Global Drug Policy will be debated at the united nations in 2016.
The voice of physicians will be heard.
822
Physicians Signed
 
Target: 1500 by January 2015
2,500 by march 2015 | 5,000 by 2016
Join Now
UNGASS
Spanish site
Naloxone
Shadow
In The News
The biggest HIV/AIDS research breakthroughs of 2014
Groundbreaking research is uncovering better ways to keep AIDS at bay and prevent HIV infection and transmission.
Reconsidering Addiction and Addiction Treatment: A Talk with Dr. Stanton Peele and DPA's asha bandele
In this "telephone call", DPA and Dr.Stanton Peele discuss the differences between problematic drug use and addiction, realistic treatment options, and the relationship between addiction, stigma and drug policy reform.
Harm reduction programs need more flexibility to work properly in Eastern Europe
Civil society expressing fears that rigidity of many opioid substitution therapy programs could drive away those who need them most.
Publications
Barriers to care and treatment for patients with chronic viral hepatitis in Europe: A systematic review Despite the availability of effective therapies for hepatitis B and C virus, only a minority of these patients receive treatment. This publication systematically reviews published data on barriers to management for chronic HBV/HCV patients in Europe.
A photo report on Swiss drug policy: Health, safety, public, order This publication explores how Switzerland’s 4 pillars drug strategy (treatment, harm reduction, prevention and law enforcement) have reduced drug-related crime, increased stability, eliminated open drug scenes, resulted in less young initiations into heroin use, improved quality of life and general health of drug users.
Drug policy in Sweden: A repressive approach that increases harm The degree to which Sweden’s low prevalence of drug use can be attributed to its repressive approach is highly questionable, as research consistently shows that wider social, economic and cultural factors are the key drivers of drug prevalence – not the harshness of enforcement.